Tower Research Capital LLC (TRC) - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 66 filers reported holding ATHIRA PHARMA INC in Q4 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2024$12,492
+1552.4%
4,559
+1365.9%
0.00%
Q4 2023$756
+131.2%
311
+92.0%
0.00%
Q3 2023$327
+1386.4%
162
-98.2%
0.00%
-100.0%
Q1 2023$22
-68.6%
8,821
-59.8%
0.00%
-66.7%
Q4 2022$70
-99.9%
21,966
+22.1%
0.00%
+200.0%
Q3 2022$53,000
+783.3%
17,991
+853.9%
0.00%
Q2 2022$6,000
-68.4%
1,886
+37.1%
0.00%
Q1 2022$19,000
+90.0%
1,376
+83.7%
0.00%
Q4 2021$10,000
-69.7%
749
-78.4%
0.00%
-100.0%
Q3 2021$33,000
+17.9%
3,462
+28.0%
0.00%0.0%
Q2 2021$28,000
+40.0%
2,704
+144.3%
0.00%
Q1 2021$20,000
+42.9%
1,107
+172.0%
0.00%
Q4 2020$14,0004070.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,864,907$5,501,4764.95%
Simplify Asset Management Inc. 1,492,792$4,403,7360.58%
Perceptive Advisors 4,797,278$14,151,9700.41%
Lynx1 Capital Management LP 193,573$571,0400.37%
Potomac Capital Management, Inc. 74,585$220,0260.23%
TANG CAPITAL MANAGEMENT LLC 352,715$1,040,5090.15%
GSA CAPITAL PARTNERS LLP 346,431$1,0220.10%
Baker Brothers Advisors 3,153,807$9,303,7310.05%
Laird Norton Wetherby Trust Company, LLC 147,309$434,5620.05%
CORNERCAP INVESTMENT COUNSEL INC 75,253$221,9960.04%
View complete list of ATHIRA PHARMA INC shareholders